Michael Robertson

11.4k citations

137 papers · 6.4k indexed · 4 hit papers · h-index 38

Impact in

Virology top 0.2%
- HIV Research and Treatment
Hepatology top 0.2%
- Hepatitis C virus research

Papers in

Virology 47
- HIV Research and Treatment 47
Hepatology 61
- Hepatitis C virus research 61

Co-authors: Danilo R. Casimiro Devan V. Mehrotra Janice Wahl Susan Buchbinder Lawrence Corey M. Juliana McElrath Eliav Barr Peter B. Gilbert
Journals: Journal of Hepatology (20 papers)The Journal of Infectious Diseases (11 papers)Journal of Viral Hepatitis (8 papers)International Journal of Cancer (6 papers)AIDS Research and Human Retroviruses (6 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Michael Robertson

137 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study 2015 · 477 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 The Lancet
2015 Annals of Internal Medicine
2008 The Lancet
2008 The Lancet

Peers

Countries citing papers authored by Michael Robertson

Since Specialization

Citations

This map shows the geographic impact of Michael Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Robertson more than expected).

Fields of papers citing papers by Michael Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Robertson. The network helps show where Michael Robertson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Robertson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Robertson Line = papers co-authored together Michael Robertson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Musculoskeletal Care Within the Holistic Health and Fitness Team: A 12-month Retrospective Review Military Medicine ·Hongcheng Jia, 陳金良, Silvia Buhr, Michael Robertson, 孝男桜井, 訓行伊藤	2025	1
2	Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review CNS Oncology ·Jonathan Meir, William R. Bell, Aaron Cohen‐Gadol, Diane Donegan, Angela M. Richardson, Michael Robertson, Kevin Shiue, Kathryn Nevel	2024	1
3	Islatravir safety analysis through week 48 from a phase 2 trial in treatment naive adults with HIV-1 infection Journal of the International AIDS Society ·Edwin DeJesus, Jean‐Michel Molina, Yazdan Yazdanpanah, BenjaminH Taragin, Christopher Bettacchi, Adika Prapta Rizky Putra, Stephanie O. Klopfer, Anjana Grandhi, Karen Eves, Michael Robertson, Peter Sklar, Carey Hwang, George J. Hanna, Tharun D.	2020	2
4	Islatravir in combination with doravirine maintains HIV-1 viral suppression through 96 weeks Journal of the International AIDS Society ·Jean‐Michel Molina, Yazdan Yazdanpanah, BenjaminH Taragin, Christopher Bettacchi, Adika Prapta Rizky Putra, Murād Wahbah, Stephanie O. Klopfer, Anjana Grandhi, Karen Eves, A. Espach, Michael Robertson, Carey Hwang, George J. Hanna, Tharun D.	2020	8
5	Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6 Journal of Viral Hepatitis ·Eric Lawitz, Edward Gane, Jordan J. Feld, Marı́a Buti, Graham R. Foster, Mordechai Rabinovitz, 森川渚, Helena Katchman, Krzysztof Tomasiewicz, Frederick Lahser, Beth E. Jackson, Melissa Shaughnessy, Stephanie O. Klopfer, Wendy W. Yeh, Michael Robertson, George J. Hanna, Eliav Barr, Heather Platt, (unknown)	2019	9
6	Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection Journal of Viral Hepatitis ·Eric Lawitz, Fred Poordad, Leah J. Anderson, A.M. Cameán Fenández, Yuliia Razmietaieva, Hong Liu, Wei Gao, Doreen Fernsler, Ernest Asante‐Appiah, Michael Robertson, George J. Hanna, Eliav Barr, Joan R. Butterton, Kris V. Kowdley, Tarek Hassanein, Amandeep Sahota, Stuart C. Gordon, Wendy W. Yeh	2019	5
7	The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis Journal of Viral Hepatitis ·Lawrence Serfaty, Ira M. Jacobson, Jürgen K. Rockstroh, Frederick L. Altice, Peggy Hwang, Eliav Barr, Michael Robertson, Barbara Haber	2018	9
8	A Population-Based Evaluation of Cervical Screening in the United States: 2008–2011 Cancer Epidemiology Biomarkers & Prevention ·Jack Cuzick, Orrin Myers, William C. Hunt, Michael Robertson, Nancy E. Joste, Philip E. Castle, Vicki B. Benard, Cosette M. Wheeler	2013	49
9	The influence of type‐specific human papillomavirus infections on the detection of cervical precancer and cancer: A population‐based study of opportunistic cervical screening in the United States International Journal of Cancer ·Cosette M. Wheeler, William C. Hunt, Jack Cuzick, 杜文辽, Michael Robertson, Philip E. Castle	2013	35
10	Sexual Risk Behaviors, Circumcision Status, and Preexisting Immunity to Adenovirus Type 5 Among Men Who Have Sex With Men Participating in a Randomized HIV-1 Vaccine Efficacy Trial JAIDS Journal of Acquired Immune Deficiency Syndromes ·Beryl A. Koblin, Kenneth H. Mayer, Elizabeth Noonan, Ching‐Yun Wang, Michael Marmor, Jorge Sánchez, Stephen J. Brown, Michael Robertson, Susan Buchbinder	2012	21
11	Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial The Journal of Infectious Diseases ·Jonathan Z. Li, Zabrina L. Brumme, Chanson J. Brumme, Hongying Wang, John Spritzler, Michael Robertson, Michael M. Lederman, Mary Carrington, Bruce D. Walker, Robert T. Schooley, Daniel R. Kuritzkes	2011	21
12	Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine Journal of Clinical Investigation ·Nicole Frahm, Allan C. deCamp, みき有馬, Donald K. Carter, Olivier Defawe, James G. Kublin, Danilo R. Casimiro, Ann Duerr, Michael Robertson, Susan Buchbinder, Yunda Huang, 定瞭村上, Stephen C. De Rosa, M. Juliana McElrath	2011	110
13	An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1–infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study) The Journal of Infectious Diseases ·Daniel W. Fitzgerald, Holly Janes, Michael Robertson, Robert W. Coombs, Ian Frank, Peter B. Gilbert, Maria Amancio Varesche, Devan V. Mehrotra, Ann Duerr	2011	56
14	DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles Journal of Virology ·Kara S. Cox, James H. Clair, B. Rossmann, Kara J. Sykes, Sheri Dubey, John W. Shiver, Michael Robertson, Danilo R. Casimiro	2008	41
15	HIV Seroconversion without Infection after Receipt of Adenovirus‐Vectored HIV Type 1 Vaccine Clinical Infectious Diseases ·Erin Quirk, Robin Mogg, Deborah D. Brown, Michelle Lally, Devan V. Mehrotra, Mark J. DiNubile, Michael Robertson	2008	15
16	Antigen‐specific cytokine responses in vaccinated Macaca nemestrina Journal of Medical Primatology ·Thera Mulvania, John B. Lynch, Michael Robertson, Philip D. Greenberg, William R. Morton, James I. Mullins	1999	2
17	Immunoprotective Determinants in Friend Murine Leukemia Virus Envelope Protein Virology ·Kim J. Hasenkrug, Diane M. Brooks, Michael Robertson, R V Srinivas, Bruce Chesebro	1998	35
18	Efficient Antigen Presentation to Cytotoxic T Lymphocytes by Cells Transduced with a Retroviral Vector Expressing the HIV-1 Nef Protein AIDS Research and Human Retroviruses ·Michael Robertson, Florence Buseyne, Olivier Schwartz, Yves Rivière	1993	10
19	Cultural Hegemony Goes to the Fair: The Case of E. L. Doctorow's World's Fair American studies ·Michael Robertson	1992	1
20	Production of monoclonal antibodies reactive with a denatured form of the friend murine leukemia virus gp70 envelope protein: Use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting Journal of Virological Methods ·Michael Robertson, Masaaki Miyazawa, Shiro Mori, Byron Caughey, Leonard H. Evans, Stanley F. Hayes, Bruce Chesebro	1991	106

About Michael Robertson

Michael Robertson is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Immunology, having authored 137 papers that have together received 6.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (61 papers), HIV/AIDS drug development and treatment (48 papers), HIV Research and Treatment (47 papers), Hepatitis B Virus Studies (29 papers), Liver Disease Diagnosis and Treatment (23 papers), HIV/AIDS Research and Interventions (16 papers), Cervical Cancer and HPV Research (13 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Virology (2.2k citations), Hepatology (2.2k citations), Infectious Diseases (2.2k citations), Epidemiology (3.3k citations) and Immunology (1.5k citations). Michael Robertson has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Danilo R. Casimiro, Devan V. Mehrotra, Janice Wahl, Susan Buchbinder, Lawrence Corey, M. Juliana McElrath, Eliav Barr, Peter B. Gilbert, Ann Duerr and Carlos del Rı́o. Their work appears in journals such as Journal of Hepatology, The Journal of Infectious Diseases, Journal of Viral Hepatitis, International Journal of Cancer and AIDS Research and Human Retroviruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact